Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic) ; volume:23 ; number:1 ; day:3 ; month:3 ; year:2021 ; pages:1-11 ; date:12.2021
Arthritis Research & Therapy ; 23, Heft 1 (3.3.2021), 1-11, 12.2021
- Urheber
-
Hamidou, Mohamed
Néel, Antoine
Poupon, Joel
Amoura, Zahir
Ebbo, Mikael
Sibilia, Jean
Viallard, Jean-Francois
Gaborit, Benjamin
Volteau, Christelle
Hardouin, Jean Benoit
Hachulla, Eric
Rieger, François
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-021-02454-6
- URN
-
urn:nbn:de:101:1-2021041707402012995759
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hamidou, Mohamed
- Néel, Antoine
- Poupon, Joel
- Amoura, Zahir
- Ebbo, Mikael
- Sibilia, Jean
- Viallard, Jean-Francois
- Gaborit, Benjamin
- Volteau, Christelle
- Hardouin, Jean Benoit
- Hachulla, Eric
- Rieger, François
- SpringerLink (Online service)
Ähnliche Objekte (12)
PML-RARA mutations confer varying arsenic trioxide resistance
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Arsenic trioxide as a novel anti-glioma drug: a review
Carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for LACC: A randomized, open-label, phase II clinical study
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
PML and its degradation by arsenic trioxide in interferon-mediated neuro-inflammation
PML-RARA mutations confer varying arsenic trioxide resistance
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Arsenic trioxide as a novel anti-glioma drug: a review
Carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for LACC: A randomized, open-label, phase II clinical study
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
PML and its degradation by arsenic trioxide in interferon-mediated neuro-inflammation
PML-RARA mutations confer varying arsenic trioxide resistance
Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae
Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
Arsenic trioxide as a novel anti-glioma drug: a review
Carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for LACC: A randomized, open-label, phase II clinical study
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9